TEXT Q1 2026/27 slides: MRR hits record as profit pressures persist

TEXT reported record recurring revenue with June 2026 MRR of $7.46M (+7.6% QoQ, +4% YoY) and Q1 2026/27 payments of $24.19M (+10.8% YoY), but profitability deteriorated: full-year EBITDA fell 23.9% and net profit declined 29.1% on heavier investment spend. Revenue also slipped 7.1% to 329.1M PLN (down 0.5% in USD terms to $88.2M), though Q4 showed sequential stabilization with EBIT up 0.3% and net profit up 0.7%. Management pointed to recovering margins into coming quarters alongside an early-stage AI/product go-to-market strategy and maintained dividends, recommending a total 4.26 PLN/share with a 0.98 PLN second interim dividend due July 29, 2026.

Analysis

The market is treating this as a “prove-it” story, not a rerating event. The hidden issue is that the company is simultaneously trying to move upmarket, add products, and retool go-to-market while still carrying the burden of a mature cash-generator: that usually means revenue quality improves before operating leverage does, and the lag can be 2-3 quarters longer than management frames it. The key question for the next 1-2 prints is whether cross-sell and pricing lift can offset the new sales process and infrastructure spend without flattening pipeline velocity.

Competitive dynamics are nuanced. The most direct pressure is on mid-market customer-support vendors and workflow tools where AI automation is becoming table stakes; bigger platforms can bundle features, but smaller specialists can still win if they show measurable ROI. The Microsoft/Shopify/Meta distribution tie-ups are more channel optionality than near-term earnings power, so they do not justify a revenue multiple expansion on their own.

Contrarian view: the dividend and recurring revenue can make this look like a “safe compounding” name, but if growth remains mostly pricing-led while margins stay volatile, the stock risks being reclassified as a cash-yield software name rather than an AI growth platform. The thesis is falsified if MRR growth slips back below mid-single digits after the grandfathering tailwind fades or if EBIT fails to recover over the next two quarters despite lower investment intensity.

Key Decisions for Investors

• No immediate position in LCHTF; treat the muted reaction as confirmation that expectations are already balanced and wait for the next quarterly print to verify margin recovery.
• If LCHTF pulls back 8-12% on post-dividend weakness without a deterioration in MRR, consider a small tactical long for a 3-6 month trade; stop if MRR growth drops below 5% QoQ.
• If the next update shows no sequential EBIT improvement, fade rallies in LCHTF rather than buying the AI narrative; the stock could de-rate to a pure cash-yield software multiple.
• Do not express the thesis through META/MSFT/SHOP here; the disclosed partnerships are distribution optics, not material earnings drivers, so they are not actionable longs on this news.